240
Views
5
CrossRef citations to date
0
Altmetric
Original Article/ Connective tissue diseases and related diseases

Associations between maternal clinical features and fetal outcomes in pregnancies of mothers with connective tissue diseases

, , , , , , , , , , , , & show all
Pages 344-350 | Received 15 Dec 2017, Accepted 08 Mar 2018, Published online: 05 Apr 2018

References

  • Tsuboi H, Sumida T, Noma H, Yamagishi K, Anami A, Fukushima K, et al. Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies. Mod Rheumatol. 2016;26:569–75.
  • Kaburaki J. Antibody specificity and related clinical features in antiphospholipid syndrome. Mod Rheumatol. 2001;11:113–20.
  • Anami A, Fukushima K, Takasaki Y, Sumida T, Waguri M, Wake N, et al. The predictive value of anti-SS-A antibodies titration in pregnant women with fetal congenital heart block. Mod Rheumatol. 2013;23:653–8.
  • Borella E, Lojacono A, Gatto M, Andreoli L, Taglietti M, Iaccarino L, et al. Predictors of maternal and fetal complications in SLE patients: a prospective study. Immunol Res. 2014;60:170–6.
  • Ideguchi H, Ohno S, Uehara T, Ishigatsubo Y. Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancy at a University Hospital. Clinic Rev Allerg Immunol. 2013;44:57–64.
  • Smyth A, Oliveira GHM, Larh BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:2060–8.
  • Sangle SR, Vounotrypidis P, Briley A, Nel L, Lutalo PMK, Sanchez-Fernandez S, et al. Pregnancy outcome in patients with systemic vasculitis: a single-centre matched case-control study. Rheumatology. 2015;54:1582–6.
  • Zhan Z, Yang Y, Zhan Y, Chen D, Liang L, Yang X. Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus. PLoS One. 2017;12:e0176457.
  • Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, et al. Predictors of pregnancy outcomes in patients with lupus. Ann Intern Med. 2015;163:153–63.
  • Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76:476–85.
  • White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Statist Med. 2011;30:377–99.
  • Tincani A, Dall'Ara F, Lazzaroni MG, Reggia R, Andreoli L. Pregnancy in patients with autoimmune disease: a reality in 2016. Autoimmun Rev. 2016;15:975–7.
  • Ogawa K, Urayama KY, Tanigaki S, Sago H, Sato S, Saito S, et al. Association between very advanced maternal age and adverse pregnancy outcomes: a cross sectional Japanese study. BMC Pregnancy Childbirth. 2017;17:349–58.
  • de Man YA, Hazes JM, van der Heide H, Willemsen SP, de Groot CJ, Steegers EA, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum. 2009;60:3196–206.
  • Comarmond C, Mirault T, Biard L, Nizard J, Lambert M, Wechsler B, et al. Takayasu arteritis and pregnancy. Arthritis Rheum. 2015;67:3262–9.
  • Orgul G, Aktoz F, Beksac MS. Behcet's disease and pregnancy: what to expect? J Obstet Gynaecol. 2017;17:1–4.
  • Shen J, Wu W, Gao C, Ochin H, Qu D, Xie J, et al. Chromosomal copy number analysis on chorionic villus samples from early spontaneous miscarriages by high throughput genetic technology. Mol Cytogenet. 2016;9:7–13.
  • Salmon JE, De Groot PG. Pathogenic role of antiphospholipid antibodies. Lupus. 2008;17:405–11.
  • Lockshin MD, Kim M, Laskin CA, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum. 2012;64:2311–18.
  • Kaneko K, Mishima S, Goto M, et al. Clinical feature and anti-phospholipid antibody profiles of pregnancy failure in young women with antiphospholipid antibody syndrome treated with conventional therapy. Mod Rheumatol. 2017;25:1–6.
  • Clowse ME, Magder LS, Witter F, et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52:514–21.
  • Moroni G, Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol. 2003;16:161–7.
  • Chakravarty EF, Colón I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;192:1897–904.
  • Nugent JL, Wareing M, Palin V, et al. Chronic glucocorticoid exposure potentiates placental chorionic plate artery constriction: implications for aberrant fetoplacental vascular resistance in fetal growth restriction. Endocrinology. 2013;154:876–87.
  • Ostensen M, Clowse M. Pathogenesis of pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol. 2013;25:591–6.
  • Bennett RM, O'Connell DJ. Mixed connective tissue disease: a clinicopathologic study of 20 cases. Semin Arthritis Rheum. 1980;10:25–51.
  • Kaufman RL, Kitridou RC. Pregnancy in mixed connective tissue disease: comparison with systemic lupus erythematosus. J Rheumatol. 1982;9:549–55.
  • Chung L, Flyckt RL, Colón I, Shah AA, Druzin M, Chakravarty EF. Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease. Lupus. 2006;15:595–9.
  • McGeachy C, Lam J. Anti-RNP neonatal lupus in a female newborn. Lupus. 2009;18:172–6.
  • Schulz SW, Bober M, Johnson C, Braverman N, Jimenez SA. Maternal mixed connective tissue disease and offspring with chondrodysplasia punctata. Semin Arthritis Rheum. 2010;39:410–16.
  • Lundberg I, Hedfors E. Pregnancy outcome in patients with high titer anti-RNP antibodies. A retrospective study of 40 pregnancies. J Rheumatol. 1991;18:359–62.
  • Ackerman J, Gonzalez EF, Gilbert-Barness E. Immunological studies of the placenta in maternal connective tissue disease. Pediatr Dev Pathol. 1999;2:19–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.